Ecnoglutide features a designed peptide backbone used for evaluating receptor-ligand interactions and structural stability under diverse conditions. Hydrophobic and charged residues contribute to its defined conformational states. Researchers analyze solvent effects and folding equilibria to understand sequence performance. Applications span peptide engineering, signaling studies, and structural optimization.
CAT No: R2452
CAS No:2459531-73-6
Synonyms/Alias:Ecnoglutide;Ecnoglutide [INN];UNII-KM6YM7L8LH;KM6YM7L8LH;2459531-73-6;GLXC-26838;DA-63110;His-Val-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr--Leu-Glu-Glu-Gln-Ala-Ala-Arg-Glu-Phe-Ile-(17-((S)-5-Hydroxy-4-(18-hydroxy-18-oxooctadecanamido)-5-oxopentanamido)-10-oxo-3,6,12,15-tetraoxa-9-azaheptadecanoyl)Lys-Trp-Leu-Val-Arg-Gly-Arg-Gly;
Ecnoglutide is a synthetic peptide analog that belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, renowned for its potent biological activity and structural stability. Designed to mimic the natural incretin hormone, Ecnoglutide exhibits enhanced resistance to enzymatic degradation, which contributes to its prolonged activity in biological systems. Its unique amino acid modifications and molecular configuration facilitate high receptor affinity, making it a valuable tool for researchers investigating metabolic pathways and peptide-receptor interactions. The versatility of Ecnoglutide allows for its integration into a variety of experimental models, providing insights into mechanisms of glucose regulation, energy metabolism, and peptide signaling. Due to its robust pharmacological profile, it has become a preferred choice for laboratories aiming to elucidate the physiological roles of GLP-1 analogs and their downstream effects in cellular and animal studies.
Metabolic Research: In the field of metabolic research, Ecnoglutide serves as a critical agent for studying glucose homeostasis and insulin secretion. Researchers employ this peptide to activate GLP-1 receptors in in vitro and in vivo models, enabling the dissection of signaling cascades that regulate blood sugar levels. Its stability and efficacy allow for the observation of both acute and sustained responses, which are essential for understanding the dynamics of glucose metabolism under various physiological and pathophysiological conditions. By modulating key metabolic pathways, this GLP-1 analog aids in identifying potential molecular targets for future therapeutic interventions.
Obesity and Appetite Regulation: Ecnoglutide is widely utilized in studies focused on appetite control and body weight regulation. By mimicking the actions of endogenous incretin hormones, it helps elucidate the neural and hormonal mechanisms that influence satiety and caloric intake. Experimental models using Ecnoglutide can reveal how GLP-1 receptor activation affects hypothalamic signaling and gut-brain communication, providing valuable data on the modulation of feeding behavior. These insights are crucial for the development of strategies aimed at managing obesity and related metabolic disorders.
Cardiovascular Function: The application of Ecnoglutide extends to cardiovascular research, where it is used to investigate the peptide's impact on heart function and vascular health. Through its interaction with GLP-1 receptors present in cardiac and vascular tissues, researchers can explore its role in modulating cardiac output, endothelial function, and inflammatory responses. Such studies are instrumental in delineating the molecular mechanisms underlying the cardioprotective effects observed with GLP-1 analogs, contributing to a deeper understanding of cardiovascular physiology.
Beta Cell Preservation: Ecnoglutide is also instrumental in studies aiming to preserve pancreatic beta cell function and mass. Its ability to stimulate GLP-1 receptors in pancreatic islets offers a platform to examine cellular processes related to proliferation, apoptosis, and insulin biosynthesis. By employing this peptide in experimental settings, scientists can assess the direct and indirect effects of GLP-1 signaling on beta cell health, which is fundamental for advancing knowledge in diabetes research and islet biology.
Neuroprotection and Cognitive Function: Research into neurodegenerative diseases and cognitive decline has increasingly incorporated Ecnoglutide due to its potential neuroprotective properties. By crossing the blood-brain barrier and activating GLP-1 receptors in neural tissues, it enables the study of neuroinflammatory pathways, synaptic plasticity, and neuronal survival. Experimental findings using this compound have shed light on the mechanisms by which GLP-1 analogs may influence brain health, offering avenues for investigating the intersection between metabolic and neurodegenerative disorders.
In summary, Ecnoglutide stands out as a multifaceted research peptide with broad applicability across metabolic, neurological, and cardiovascular studies. Its stability, receptor specificity, and biological activity make it an indispensable tool for probing GLP-1 mediated pathways and for advancing our understanding of complex physiological systems. Whether employed in metabolic profiling, appetite regulation, cardiovascular function, beta cell preservation, or neuroprotection, this GLP-1 analog continues to drive innovation and discovery in basic and translational research settings.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More